Taste alteration in breast cancer patients treated with taxane chemotherapy: Experience, effect, and coping strategies

Supportive Care in Cancer

Volumn 21, Issue 2, 2013, Pages 549-555

  Speck, Rebecca M ^a   Demichele, Angela ^a   Farrar, John T ^a   Hennessy, Sean ^a   Mao, Jun J ^a   Stineman, Margaret G ^a   Barg, Frances K ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Breast cancer; Chemotherapy; Dysgeusia; Taste

Indexed keywords

DOCETAXEL; PACLITAXEL; TAXANE DERIVATIVE; TRASTUZUMAB;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; CUTTING FOOD WITH LEMON; DRINKING FROM A STRAW; DRINKING SWEETENED DRINK; DYSGEUSIA; EATING CANDY BEFORE MEAL; FEEDING BEHAVIOR; FEMALE; FOOD; FOOD CRAVING; FOOD INTAKE; HUMAN; HYPERGEUSIA; HYPOGEUSIA; MOUTH HYGIENE; MULTIPLE CYCLE TREATMENT; PARAGEUSIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SELF CARE; SEMI STRUCTURED INTERVIEW; STRONGLY FLAVORED FOOD; TASTE DISORDER; TOOTH BRUSHING; USING PLASTIC EATING UTENSIL;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; DYSGEUSIA; EATING DISORDERS; FEMALE; FLAVORING AGENTS; HUMANS; INTERVIEWS AS TOPIC; MIDDLE AGED; PACLITAXEL; QUALITATIVE RESEARCH; SPICES; TASTE; TAXOIDS; YOUNG ADULT;

EID: 84874110896     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1551-3     Document Type: Article

References (39)

1. Comeau TB, Epstein JB, Migas C (2001) Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge. Support Care Cancer 9:575-580
2. Hong JH, Omur-Ozbek P, Stanek BT et al (2009) Taste and odor abnormalities in cancer patients. J Support Oncol 7:58-65
3. Hovan AJ, Williams PM, Stevenson-Moore P et al (2010) A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 18:1081-1087
4. Berteretche MV, Dalix AM, d'Ornano AM et al (2004) Decreased taste sensitivity in cancer patients under chemotherapy. Support Care Cancer 12:571-576
5. Mattsson T, Arvidson K, Heimdahl A et al (1992) Alterations in taste acuity associated with allogeneic bone marrow transplantation. J Oral Pathol Med 21:33-37
6. Mulder NH, Smit JM, Kreumer WM et al (1983) Effect of chemotherapy on taste sensation in patients with disseminated malignant melanoma. Oncology 40:36-38
7. Steinbach S, Hummel T, Bohner C et al (2009) Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies. J Clin Oncol 27:1899-1905
8. Sanchez-Lara K, Sosa-Sanchez R, Green-Renner D et al (2010) Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy. Nutr J 9:15
9. Epstein JB, Phillips N, Parry J et al (2002) Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 30:785-792
10. Rhodes VA, McDaniel RW, Hanson B et al (1994) Sensory perception of patients on selected antineoplastic chemotherapy protocols. Cancer Nurs 17:45-51
11. Zabernigg A, Gamper EM, Giesinger JM et al (2010) Taste alterations in cancer patients receiving chemotherapy: a neglected side effect? Oncologist 15:913-920
12. Bernhardson BM, Tishelman C, Rutqvist LE (2008) Self-reported taste and smell changes during cancer chemotherapy. Support Care Cancer 16:275-283
13. Jensen SB, Mouridsen HT, Bergmann OJ et al (2008) Oral mucosal lesions, microbial changes, and taste disturbances induced by adjuvant chemotherapy in breast cancer patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:217-226
14. Bernhardson BM, Tishelman C, Rutqvist LE (2007) Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study. J Pain Symptom Manag 34:403-412
15. Rehwaldt M, Wickham R, Purl S et al (2009) Self-care strategies to cope with taste changes after chemotherapy. Oncol Nurs Forum 36:E47-E56
16. Bernhardson BM, Tishelman C, Rutqvist LE (2009) Taste and smell changes in patients receiving cancer chemotherapy - distress, impact on daily life, and self-care strategies. Cancer Nurs 32:45-54
17. Maxwell J (1997) Designing a qualitative study. In: Bickman L, Rog DJ (eds) Handbook of applied social research methods. Sage, Thousand Oaks, pp 69-100
18. Patton M (2002) Qualitative research and evaluation methods. Sage, London
19. Speck RM, Demichele A, Farrar JT, et al. (2012) Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients. Support Care Cancer Jan 11 [Epub ahead of print]
20. QSR International (2008) Nvivo qualitative data analysis software, (ed version 8). QSR International Pty Ltd
21. Boeije H (2002) A purposeful approach to the constant comparative method in the analysis of qualitative interviews. Qual Quant 36:391-409
22. Velos I (2011) Velos eResearch. Velos, Inc., Fremont
23. Macquart-Moulin G, Viens P, Palangie T et al (2000) High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment? J Clin Oncol 18:754-764
24. Heasman KZ, Sutherland HJ, Campbell JA et al (1985) Weight gain during adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat 5:195-200
25. Hernandez BM, Bonomi P, Hoeltgen T (1983) Weight gain during adjuvant chemotherapy for stage II breast cancer. Proc Am Soc Clin Oncol 2:108
26. Foltz AT (1985) Weight gain among stage II breast cancer patients: a study of five factors. Oncol Nurs Forum 12:21-26
27. Chlebowski RT, Aiello E, McTiernan A (2002) Weight loss in breast cancer patient management. J Clin Oncol 20:1128-1143
28. Loi S, Milne RL, Friedlander ML et al (2005) Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 14:1686-1691
29. Janni JW, Hepp PGM, Andergassen U et al (2011) Final multivariate analysis of obesity and survival in patients with node-positive primary breast cancer: the ADEBAR trial. J Clin Oncol 29:abstr 1020
30. Gluz O, Liedtke C, Kates RE et al (2011) Molecular subtypes, body mass index (BMI), and their time-varying prognostic impact in node-positive breast cancer (BC): pooled analysis from the WSG AM-01 and -02 trials. J Clin Oncol 29:abstr 1021
31. Hepp PGM, Rack B, Annecke K, et al. (2010) Multivariate analysis of obesity and disease free survival in patients with nodal positive primary breast cancer - the ADEBAR Trial. San Antonio Breast Cancer Symposium, 2010. http://www.success-studie.de/portal/publikationen/2010/Hepp-SABCS-vortrag2010. pdf Accessed 3 March 2012
32. Berclaz G, Li S, Price KN et al (2004) Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol 15:875-884
33. de Azambuja E, McCaskill-Stevens W, Francis P et al (2010) The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial. Breast Cancer Res Treat 119:145-153
34. Sparano JA, Wang M, Martino S, et al. (2010) Obesity at diagnosis is associated with inferior outcomes in hormone receptor positive breast cancer. San Antonio Breast Cancer Symp, 2010: abstr S2-1
35. Heckmann JG, Heckmann SM, Lang CJ et al (2003) Neurological aspects of taste disorders. Arch Neurol 60:667-671
36. Fan G, Filipczak L, Chow E (2007) Symptom clusters in cancer patients: a review of the literature. Curr Oncol 14:173-179
37. National Cancer Institute (2009) Common terminology criteria for adverse events v4.0. NCI, NIH, DHHS. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4.03-2010- 06-14-QuickReference-5x7.pdf Accessed 10 August 2011
38. Wickham RS, Rehwaldt M, Kefer C et al (1999) Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum 26:697-706
39. Cella D, Peterman A, Hudgens S et al (2003) Measuring the side effects of taxane therapy in oncology: the functional assesment of cancer therapy-taxane (FACT-taxane). Cancer 98:822-831